Path BioAnalytics, Inc.
Precision Medicine — Made Possible
Chapel Hill, United States · Founded 2016
- Headquarters
- Chapel Hill, North Carolina
- Employees
- 1–10
- Founded
- 2016
- Business Model
- B2B
- Website
- pathbioanalytics.com
About
Path BioAnalytics (PBA) is a translational drug development company that uses high-throughput organoid-based assays, a proprietary biobank, and computational tools to accelerate drug discovery for rare diseases. PBA has particular expertise in pulmonology including cystic fibrosis CFTR modulator research. The company was awarded a Phase II SBIR grant from NIH for its non-invasive nasal organoid platform.
Summary
Path BioAnalytics, Inc. is a Biotech company based in Chapel Hill, United States, founded in 2016.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/path-bioanalytics-inc"><img src="https://indexed.vc/api/badge/company/path-bioanalytics-inc" alt="Path BioAnalytics, Inc. on Indexed.vc" width="260" height="76" /></a>